Aktie SILCOPHL SILCO PHARMACEUTICALS LIMITED
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Silco Pharmaceuticals Limited

Aktien

SILCOPHL

BD0495SILCO6

SILCOPHL

Schlusskurs Dhaka S.E.
Andere Börsenplätze
 00:00:00 27.06.2024 		% 5 Tage % 1. Jan.
17,4 BDT -0,57 % Intraday Chart für Silco Pharmaceuticals Limited -1,69 % -25,64 %
01.05. Silco Pharmaceuticals Limited meldet Ergebnis für das dritte Quartal und die neun Monate bis zum 31. März 2024 CI
07.02. Silco Pharmaceuticals Limited meldet Gewinnergebnisse für das zweite Quartal und die sechs Monate bis zum 31. Dezember 2023 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!
100% kostenlose Registrierung
Silco Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024
Silco Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023
Silco Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended September 30, 2023
Silco Pharmaceuticals Limited Recommends Cash Dividend for All Shareholders Excluding Directors for the Year Ended June 30, 2023
Silco Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023
Silco Pharmaceuticals Limited Approves Cash Dividend for the Year Ended June 30, 2022
Silco Pharmaceuticals Limited Recommends Cash Dividend for the Year Ended June 30, 2022
37,316,700 Ordinary Shares of Silco Pharmaceuticals Limited are subject to a Lock-Up Agreement Ending on 11-FEB-2022.
Silco Pharmaceuticals Limited Recommends Cash Dividend for the Year Ended on June 30, 2021
Silco Pharmaceuticals Limited Recommends Cash Dividend for the Year Ended on June 30, 2020
Silco Pharmaceuticals Limited Reports Earnings Results for the Year Ended on June 30, 2020
Silco Pharmaceuticals Limited Signs First Export Agreement with Zaid Elyas Adil Ltd
27,053,300 Ordinary Shares of Silco Pharmaceuticals Limited are subject to a Lock-Up Agreement Ending on 11-FEB-2020.
Silco Pharmaceuticals Limited Recommends Dividend for the Year Ended June 30, 2019
Silco Pharmaceuticals Limited Announces Earnings Results for the Third Quarter and Nine Months Ended Period Ended on 31 March 2019
Silco Pharmaceuticals Limited has completed an IPO in the amount of BDT 300 million.
Silco Pharmaceuticals Limited has filed an IPO in the amount of BDT 300 million.
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. SILCOPHL Aktie
  4. Nachrichten Silco Pharmaceuticals Limited
  5. Andere Sprachen